James Arvid Waschek - Publications

University of California, Los Angeles, Los Angeles, CA 

145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Łastowska M, Karkucińska-Więckowska A, Waschek JA, Niewiadomski P. Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma. Cells. 8. PMID 30841515 DOI: 10.3390/cells8030216  0.72
2017 Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio MS, Waschek JA, Tan YV. Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. Journal of Neuroinflammation. 14: 157. PMID 28778207 DOI: 10.1186/s12974-017-0927-1  0.76
2017 Waschek JA, Cohen JR, Chi GC, Proszynski TJ, Niewiadomski P. PACAP Promotes Matrix-Driven Adhesion of Cultured Adult Murine Neural Progenitors. Asn Neuro. 9: 1759091417708720. PMID 28523979 DOI: 10.1177/1759091417708720  0.72
2016 Missig G, Mei L, Vizzard MA, Braas KM, Waschek JA, Ressler KJ, Hammack SE, May V. Parabrachial Pituitary Adenylate Cyclase Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain. Biological Psychiatry. PMID 28057459 DOI: 10.1016/j.biopsych.2016.08.025  0.32
2016 Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio MS, Waschek JA, Tan YV. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. Journal of Neuroinflammation. 13: 169. PMID 27357191 DOI: 10.1186/s12974-016-0626-3  0.76
2016 Condro MC, Matynia A, Foster NN, Ago Y, Rajbhandari AK, Jayaram B, Parikh S, Diep AL, Nguyen E, May V, Dong HW, Waschek JA. High-resolution characterization of a PACAP-EGFP transgenic mouse model for mapping PACAP-expressing neurons. The Journal of Comparative Neurology. PMID 27197019 DOI: 10.1002/cne.24035  0.76
2015 Marzagalli R, Scuderi S, Drago F, Waschek JA, Castorina A. Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications. International Journal of Endocrinology. 2015: 160928. PMID 26074958 DOI: 10.1155/2015/160928  0.76
2015 Wu X, Conlin VS, Morampudi V, Ryz NR, Nasser Y, Bhinder G, Bergstrom KS, Yu HB, Waterhouse CC, Buchan AM, Popescu OE, Gibson WT, Waschek JA, Vallance BA, Jacobson K. Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. Plos One. 10: e0125225. PMID 25932952 DOI: 10.1371/journal.pone.0125225  0.76
2015 Vu JP, Larauche M, Flores M, Luong L, Norris J, Oh S, Liang LJ, Waschek J, Pisegna JR, Germano PM. Regulation of Appetite, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP). Journal of Molecular Neuroscience : Mn. 56: 377-87. PMID 25904310 DOI: 10.1007/s12031-015-0556-z  0.76
2015 Shibasaki Y, Hayata-Takano A, Hazama K, Nakazawa T, Shintani N, Kasai A, Nagayasu K, Hashimoto R, Tanida M, Katayama T, Matsuzaki S, Yamada K, Taniike M, Onaka Y, Ago Y, ... Waschek JA, et al. Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide. Neuroscience. 297: 95-104. PMID 25841321 DOI: 10.1016/j.neuroscience.2015.03.062  0.76
2015 Onaka Y, Shintani N, Nakazawa T, Haba R, Ago Y, Wang H, Kanoh T, Hayata-Takano A, Hirai H, Nagata KY, Nakamura M, Hashimoto R, Matsuda T, Waschek JA, Kasai A, et al. CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice. Behavioural Brain Research. 284: 131-7. PMID 25698598 DOI: 10.1016/j.bbr.2015.02.013  0.76
2015 Castorina A, Waschek JA, Marzagalli R, Cardile V, Drago F. PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures. Plos One. 10: e0117799. PMID 25658447 DOI: 10.1371/journal.pone.0117799  0.76
2015 Ago Y, Condro MC, Tan YV, Ghiani CA, Colwell CS, Cushman JD, Fanselow MS, Hashimoto H, Waschek JA. Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist. Psychopharmacology. 232: 2181-9. PMID 25575489 DOI: 10.1007/s00213-014-3848-z  0.76
2015 Yamasaki A, Kasai A, Toi A, Kurita M, Kimoto S, Hayata-Takano A, Nakazawa T, Nagayasu K, Shintani N, Hashimoto R, Ito A, Meltzer HY, Ago Y, Waschek JA, Onaka Y, et al. Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro. Journal of Neurochemistry. 132: 418-28. PMID 25421849 DOI: 10.1111/jnc.12999  0.76
2015 Tan YV, Abad C, Wang Y, Lopez R, Waschek JA. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses. Brain, Behavior, and Immunity. 44: 167-75. PMID 25305591 DOI: 10.1016/j.bbi.2014.09.020  0.76
2015 Abad C, Cheung-Lau G, Coûté-Monvoisin AC, Waschek JA. Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis. Neuroimmunomodulation. 22: 203-12. PMID 25301381 DOI: 10.1159/000364912  0.76
2014 Vu JP, Million M, Larauche M, Luong L, Norris J, Waschek JA, Pothoulakis C, Pisegna JR, Germano PM. Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice. Journal of Molecular Neuroscience : Mn. 52: 37-47. PMID 24395090 DOI: 10.1007/s12031-013-0205-3  0.76
2014 Kim KD, Srikanth S, Tan YV, Yee MK, Jew M, Damoiseaux R, Jung ME, Shimizu S, An DS, Ribalet B, Waschek JA, Gwack Y. Calcium signaling via Orai1 is essential for induction of the nuclear orphan receptor pathway to drive Th17 differentiation. Journal of Immunology (Baltimore, Md. : 1950). 192: 110-22. PMID 24307733 DOI: 10.4049/jimmunol.1302586  0.76
2014 Abad C, Nobuta H, Li J, Kasai A, Yong WH, Waschek JA. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma. Journal of Leukocyte Biology. 95: 357-67. PMID 24068730 DOI: 10.1189/jlb.1012531  0.76
2013 Niewiadomski P, Zhujiang A, Youssef M, Waschek JA. Interaction of PACAP with Sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA. Cellular Signalling. 25: 2222-30. PMID 23872071 DOI: 10.1016/j.cellsig.2013.07.012  0.76
2013 Ji H, Zhang Y, Liu Y, Shen XD, Gao F, Nguyen TT, Busuttil RW, Waschek JA, Kupiec-Weglinski JW. Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 19: 945-56. PMID 23744729 DOI: 10.1002/lt.23681  0.76
2013 Tan YV, Abad C, Wang Y, Lopez R, Waschek JA. Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE. Plos One. 8: e61200. PMID 23613811 DOI: 10.1371/journal.pone.0061200  0.76
2013 Waschek JA. VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. British Journal of Pharmacology. 169: 512-23. PMID 23517078 DOI: 10.1111/bph.12181  0.76
2013 Watson MB, Nobuta H, Abad C, Lee SK, Bala N, Zhu C, Richter F, Chesselet MF, Waschek JA. PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice. Neuroscience. 240: 277-86. PMID 23500093 DOI: 10.1016/j.neuroscience.2013.03.002  0.76
2013 Tyagi E, Agrawal R, Zhuang Y, Abad C, Waschek JA, Gomez-Pinilla F. Vulnerability imposed by diet and brain trauma for anxiety-like phenotype: implications for post-traumatic stress disorders. Plos One. 8: e57945. PMID 23483949 DOI: 10.1371/journal.pone.0057945  0.76
2013 Yan Y, Zhou X, Pan Z, Ma J, Waschek JA, DiCicco-Bloom E. Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 3865-78. PMID 23447598 DOI: 10.1523/JNEUROSCI.1062-12.2013  0.76
2013 Ji H, Zhang Y, Shen XD, Gao F, Huang CY, Abad C, Busuttil RW, Waschek JA, Kupiec-Weglinski JW. Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway. Hepatology (Baltimore, Md.). 57: 1225-37. PMID 22532103 DOI: 10.1002/hep.25802  0.76
2013 Abad C, Tan YV, Cheung-Lau G, Nobuta H, Waschek JA. Correction: VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses (PLoS ONE) Plos One. 8. DOI: 10.1371/annotation/c70f1786-cb3f-4677-9a7c-0182dfbec74c  0.76
2012 Abad C, Gomariz R, Waschek J, Leceta J, Martinez C, Juarranz Y, Arranz A. VIP in inflammatory bowel disease: state of the art. Endocrine, Metabolic & Immune Disorders Drug Targets. 12: 316-22. PMID 23094828 DOI: 10.2174/187153012803832576  0.76
2012 Nobuta H, Ghiani CA, Paez PM, Spreuer V, Dong H, Korsak RA, Manukyan A, Li J, Vinters HV, Huang EJ, Rowitch DH, Sofroniew MV, Campagnoni AT, de Vellis J, Waschek JA. STAT3-mediated astrogliosis protects myelin development in neonatal brain injury. Annals of Neurology. 72: 750-65. PMID 22941903 DOI: 10.1002/ana.23670  0.76
2012 Abad C, Tan YV, Cheung-Lau G, Nobuta H, Waschek JA. VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses. Plos One. 7: e36922. PMID 22615845 DOI: 10.1371/journal.pone.0036922  0.76
2012 Yusta B, Holland D, Waschek JA, Drucker DJ. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice. Endocrinology. 153: 2623-32. PMID 22535770 DOI: 10.1210/en.2012-1069  0.76
2012 Waschek JA. Noggin on heaven's door: a factor that promotes the selective production of serotonergic neurons from murine embryonic stem cells and induced pluripotent stem cells. Journal of Neurochemistry. 122: 1-3. PMID 22420625 DOI: 10.1111/j.1471-4159.2012.07732.x  0.76
2012 Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. British Journal of Pharmacology. 166: 4-17. PMID 22289055 DOI: 10.1111/j.1476-5381.2012.01871.x  0.76
2011 Ghiani CA, Mattan NS, Nobuta H, Malvar JS, Boles J, Ross MG, Waschek JA, Carpenter EM, Fisher RS, de Vellis J. Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat. Asn Neuro. 3. PMID 22007738 DOI: 10.1042/AN20110027  0.76
2011 Tan YV, Waschek JA. Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis. Asn Neuro. 3. PMID 21895607 DOI: 10.1042/AN20110024  0.76
2011 Li JM, Southerland L, Hossain MS, Giver CR, Wang Y, Darlak K, Harris W, Waschek J, Waller EK. Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice. Journal of Immunology (Baltimore, Md. : 1950). 187: 1057-65. PMID 21677142 DOI: 10.4049/jimmunol.1100686  0.76
2011 Hirose M, Niewiadomski P, Tse G, Chi GC, Dong H, Lee A, Carpenter EM, Waschek JA. Pituitary adenylyl cyclase-activating peptide counteracts hedgehog-dependent motor neuron production in mouse embryonic stem cell cultures. Journal of Neuroscience Research. 89: 1363-74. PMID 21674568 DOI: 10.1002/jnr.22675  0.76
2011 Loh DH, Dragich JM, Kudo T, Schroeder AM, Nakamura TJ, Waschek JA, Block GD, Colwell CS. Effects of vasoactive intestinal peptide genotype on circadian gene expression in the suprachiasmatic nucleus and peripheral organs. Journal of Biological Rhythms. 26: 200-9. PMID 21628547 DOI: 10.1177/0748730411401740  0.76
2011 Abad C, Waschek JA. Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis. Current Pharmaceutical Design. 17: 1025-35. PMID 21524252 DOI: 10.2174/138161211795589364  0.76
2011 Alexandre D, Alonzeau J, Bill BR, Ekker SC, Waschek JA. Expression analysis of PAC1-R and PACAP genes in zebrafish embryos. Journal of Molecular Neuroscience : Mn. 43: 94-100. PMID 20526695 DOI: 10.1007/s12031-010-9397-y  0.76
2011 Teuchner B, Dimmer A, Humpel C, Amberger A, Fischer-Colbrie R, Nemeth J, Waschek JA, Kieselbach G, Kralinger M, Schmid E, Bechrakis N, Troger J. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina. Acta Ophthalmologica. 89: 670-5. PMID 20064115 DOI: 10.1111/j.1755-3768.2009.01828.x  0.76
2010 Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM, Waschek JA. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. Bmc Cancer. 10: 676. PMID 21143927 DOI: 10.1186/1471-2407-10-676  0.76
2010 Abad C, Tan YV, Lopez R, Nobuta H, Dong H, Phan P, Feng JM, Campagnoni AT, Waschek JA. Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 107: 19555-60. PMID 20978211 DOI: 10.1073/pnas.1007622107  0.76
2010 Dragich JM, Loh DH, Wang LM, Vosko AM, Kudo T, Nakamura TJ, Odom IH, Tateyama S, Hagopian A, Waschek JA, Colwell CS. The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus. The European Journal of Neuroscience. 31: 864-75. PMID 20180841 DOI: 10.1111/j.1460-9568.2010.07119.x  0.76
2010 Martin B, Shin YK, White CM, Ji S, Kim W, Carlson OD, Napora JK, Chadwick W, Chapter M, Waschek JA, Mattson MP, Maudsley S, Egan JM. Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression. Diabetes. 59: 1143-52. PMID 20150284 DOI: 10.2337/db09-0807  0.76
2009 Kim WK, Meliton V, Park KW, Hong C, Tontonoz P, Niewiadomski P, Waschek JA, Tetradis S, Parhami F. Negative regulation of Hedgehog signaling by liver X receptors. Molecular Endocrinology (Baltimore, Md.). 23: 1532-43. PMID 19608643 DOI: 10.1210/me.2008-0453  0.76
2009 Marquez P, Bebawy D, Lelièvre V, Coûté AC, Evans CJ, Waschek JA, Lutfy K. The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice. Psychopharmacology. 204: 457-63. PMID 19199096 DOI: 10.1007/s00213-009-1476-9  0.76
2009 Tan YV, Abad C, Lopez R, Dong H, Liu S, Lee A, Gomariz RP, Leceta J, Waschek JA. Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 106: 2012-7. PMID 19190179 DOI: 10.1073/pnas.0812257106  0.76
2008 Loh DH, Abad C, Colwell CS, Waschek JA. Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids. Neuroendocrinology. 88: 246-55. PMID 18562786 DOI: 10.1159/000140676  0.76
2008 Studeny S, Cheppudira BP, Meyers S, Balestreire EM, Apodaca G, Birder LA, Braas KM, Waschek JA, May V, Vizzard MA. Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice. Journal of Molecular Neuroscience : Mn. 36: 175-87. PMID 18561033 DOI: 10.1007/s12031-008-9100-8  0.76
2008 Niewiadomski P, Coûté-Monvoisin AC, Abad C, Ngo D, Menezes A, Waschek JA. Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death. Journal of Molecular Neuroscience : Mn. 36: 200-7. PMID 18491042 DOI: 10.1007/s12031-008-9085-3  0.76
2008 Girard BM, Malley SE, Braas KM, Waschek JA, May V, Vizzard MA. Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. Journal of Molecular Neuroscience : Mn. 36: 188-99. PMID 18483878 DOI: 10.1007/s12031-008-9084-4  0.76
2008 Lim MA, Stack CM, Cuasay K, Stone MM, McFarlane HG, Waschek JA, Hill JM. Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 26: 423-34. PMID 18423945 DOI: 10.1016/j.ijdevneu.2008.03.002  0.76
2008 Stack CM, Lim MA, Cuasay K, Stone MM, Seibert KM, Spivak-Pohis I, Crawley JN, Waschek JA, Hill JM. Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Experimental Neurology. 211: 67-84. PMID 18316078 DOI: 10.1016/j.expneurol.2008.01.003  0.76
2008 Jensen DG, Studeny S, May V, Waschek J, Vizzard MA. Expression of phosphorylated cAMP response element binding protein (p-CREB) in bladder afferent pathways in VIP-/- mice with cyclophosphamide (CYP)-induced cystitis. Journal of Molecular Neuroscience : Mn. 36: 299-309. PMID 18299998 DOI: 10.1007/s12031-008-9045-y  0.76
2008 Nemetz N, Abad C, Lawson G, Nobuta H, Chhith S, Duong L, Tse G, Braun J, Waschek JA. Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. International Journal of Cancer. Journal International Du Cancer. 122: 1803-9. PMID 18098289 DOI: 10.1002/ijc.23308  0.76
2008 Armstrong BD, Abad C, Chhith S, Cheung-Lau G, Hajji OE, Nobuta H, Waschek JA. Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience. 151: 63-73. PMID 18055122 DOI: 10.1016/j.neuroscience.2007.09.084  0.76
2008 Lelievre V, Seksenyan A, Nobuta H, Yong WH, Chhith S, Niewiadomski P, Cohen JR, Dong H, Flores A, Liau LM, Kornblum HI, Scott MP, Waschek JA. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice. Developmental Biology. 313: 359-70. PMID 18036580 DOI: 10.1016/j.ydbio.2007.10.031  0.76
2008 Nakano I, Masterman-Smith M, Saigusa K, Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R, Howes A, Lelievre V, Waschek JA, Lazareff JA, Freije WA, Liau LM, et al. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. Journal of Neuroscience Research. 86: 48-60. PMID 17722061 DOI: 10.1002/jnr.21471  0.76
2007 Koh SW, Guo Y, Bernstein SL, Waschek JA, Liu X, Symes AJ. Vasoactive intestinal peptide induction by ciliary neurotrophic factor in donor human corneal endothelium in situ. Neuroscience Letters. 423: 89-94. PMID 17692461 DOI: 10.1016/j.neulet.2007.05.067  0.76
2007 Lelievre V, Favrais G, Abad C, Adle-Biassette H, Lu Y, Germano PM, Cheung-Lau G, Pisegna JR, Gressens P, Lawson G, Waschek JA. Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease. Peptides. 28: 1688-99. PMID 17606312 DOI: 10.1016/j.peptides.2007.05.006  0.76
2007 Lacombe A, Lelievre V, Roselli CE, Muller JM, Waschek JA, Vilain E. Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis. The Journal of Endocrinology. 194: 153-60. PMID 17592029 DOI: 10.1677/JOE-07-0102  0.76
2007 Said SI, Hamidi SA, Dickman KG, Szema AM, Lyubsky S, Lin RZ, Jiang YP, Chen JJ, Waschek JA, Kort S. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation. 115: 1260-8. PMID 17309917 DOI: 10.1161/CIRCULATIONAHA.106.681718  0.76
2007 Brown TM, Colwell CS, Waschek JA, Piggins HD. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice. Journal of Neurophysiology. 97: 2553-8. PMID 17151217 DOI: 10.1152/jn.01206.2006  0.76
2007 Lacombe A, Lelievre V, Roselli CE, Muller JM, Waschek JA, Vilain E. Role of vasoactive intestinal peptide (VIP) in steroidogenesis and aging in mouse testis | Rôle du peptide vasoactif intestinal (VIP) dans la stéroïdogenèse et le vieillissement testiculaire Andrologie. 17: 123-128.  0.76
2006 Girard BA, Lelievre V, Braas KM, Razinia T, Vizzard MA, Ioffe Y, El Meskini R, Ronnett GV, Waschek JA, May V. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. Journal of Neurochemistry. 99: 499-513. PMID 17029602 DOI: 10.1111/j.1471-4159.2006.04112.x  0.76
2006 Lacombe A, Lelièvre V, Roselli CE, Salameh W, Lue YH, Lawson G, Muller JM, Waschek JA, Vilain E. [A neuropeptide at the origin of testicular aging?]. MéDecine Sciences : M/S. 22: 809-11. PMID 17026927 DOI: 10.1051/medsci/20062210809  0.76
2006 Lelievre V, Ghiani CA, Seksenyan A, Gressens P, de Vellis J, Waschek JA. Growth factor-dependent actions of PACAP on oligodendrocyte progenitor proliferation. Regulatory Peptides. 137: 58-66. PMID 16989910 DOI: 10.1016/j.regpep.2006.04.024  0.76
2006 Waschek JA, Dicicco-Bloom E, Nicot A, Lelievre V. Hedgehog signaling: new targets for GPCRs coupled to cAMP and protein kinase A. Annals of the New York Academy of Sciences. 1070: 120-8. PMID 16888153 DOI: 10.1196/annals.1317.089  0.76
2006 Hamidi SA, Szema AM, Lyubsky S, Dickman KG, Degene A, Mathew SM, Waschek JA, Said SI. Clues to VIP function from knockout mice. Annals of the New York Academy of Sciences. 1070: 5-9. PMID 16888146 DOI: 10.1196/annals.1317.035  0.76
2006 Szema AM, Hamidi SA, Lyubsky S, Dickman KG, Mathew S, Abdel-Razek T, Chen JJ, Waschek JA, Said SI. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. American Journal of Physiology. Lung Cellular and Molecular Physiology. 291: L880-6. PMID 16782752 DOI: 10.1152/ajplung.00499.2005  0.76
2006 Lelièvre V, Hu Z, Ioffe Y, Byun JY, Flores A, Seksenyan A, Waschek JA. Paradoxical antagonism of PACAP receptor signaling by VIP in Xenopus oocytes via the type-C natriuretic peptide receptor. Cellular Signalling. 18: 2013-21. PMID 16723209 DOI: 10.1016/j.cellsig.2006.03.013  0.76
2006 Lacombe A, Lelievre V, Roselli CE, Salameh W, Lue YH, Lawson G, Muller JM, Waschek JA, Vilain E. Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 3793-8. PMID 16505386 DOI: 10.1073/pnas.0505827103  0.76
2006 Armstrong BD, Abad C, Chhith S, Cheung-Lau G, Hajji OE, Coute AC, Ngo DH, Waschek JA. Impairment of axotomy-induced pituitary adenylyl cyclase-activating peptide gene expression in T helper 2 lymphocyte-deficient mice. Neuroreport. 17: 309-12. PMID 16462603 DOI: 10.1097/01.wnr.0000199465.54907.74  0.76
2006 Abad C, Gomariz RP, Waschek JA. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Current Topics in Medicinal Chemistry. 6: 151-63. PMID 16454764 DOI: 10.2174/156802606775270288  0.76
2006 Galbraith G, Waschek J, Armstrong B, Edmond J, Lopez I, Liu W, Kurtz I. Murine auditory brainstem evoked response: putative two-channel differentiation of peripheral and central neural pathways. Journal of Neuroscience Methods. 153: 214-20. PMID 16406043 DOI: 10.1016/j.jneumeth.2005.10.017  0.76
2006 Abad C, Niewiadomski P, Loh DHW, Waschek JA. Neurotransmitter and immunomodulatory actions of VIP and PACAP: Lessons from knockout mice International Journal of Peptide Research and Therapeutics. 12: 297-310. DOI: 10.1007/s10989-006-9032-5  0.76
2005 Aton SJ, Colwell CS, Harmar AJ, Waschek J, Herzog ED. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nature Neuroscience. 8: 476-83. PMID 15750589 DOI: 10.1038/nn1419  0.76
2004 Armstrong BD, Abad C, Chhith S, Rodriguez W, Cheung-Lau G, Trinh V, Waschek JA. Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+ T-lymphocytes. Neuroreport. 15: 2647-50. PMID 15570170 DOI: 10.1097/00001756-200412030-00018  0.76
2004 Armstrong BD, Hu Z, Abad C, Yamamoto M, Rodriguez WI, Cheng J, Lee M, Chhith S, Gomariz RP, Waschek JA. Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice. Neuroscience. 129: 93-9. PMID 15489032 DOI: 10.1016/j.neuroscience.2004.06.085  0.76
2004 Waschek JA. Developmental actions of natriuretic peptides in the brain and skeleton. Cellular and Molecular Life Sciences : Cmls. 61: 2332-42. PMID 15378204 DOI: 10.1007/s00018-004-4159-z  0.76
2004 Colwell CS, Michel S, Itri J, Rodriguez W, Tam J, Lelièvre V, Hu Z, Waschek JA. Selective deficits in the circadian light response in mice lacking PACAP. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 287: R1194-201. PMID 15217792 DOI: 10.1152/ajpregu.00268.2004  0.76
2004 DiCicco-Bloom E, Lelièvre V, Zhou X, Rodriguez W, Tam J, Waschek JA. Embryonic expression and multifunctional actions of the natriuretic peptides and receptors in the developing nervous system. Developmental Biology. 271: 161-75. PMID 15196958 DOI: 10.1016/j.ydbio.2004.03.028  0.76
2004 Itri J, Michel S, Waschek JA, Colwell CS. Circadian rhythm in inhibitory synaptic transmission in the mouse suprachiasmatic nucleus. Journal of Neurophysiology. 92: 311-9. PMID 14973316 DOI: 10.1152/jn.01078.2003  0.76
2004 Armstrong BD, Paik E, Chhith S, Lelievre V, Waschek JA, Howard SG. Potentiation of (DL)-3,4-methylenedioxymethamphetamine (MDMA)-induced toxicity by the serotonin 2A receptor partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist MDL 11,939 Neuroscience Research Communications. 35: 83-95. DOI: 10.1002/nrc.20023  0.76
2003 Armstrong BD, Hu Z, Abad C, Yamamoto M, Rodriguez WI, Cheng J, Tam J, Gomariz RP, Patterson PH, Waschek JA. Lymphocyte regulation of neuropeptide gene expression after neuronal injury. Journal of Neuroscience Research. 74: 240-7. PMID 14515353 DOI: 10.1002/jnr.10750  0.76
2003 Colwell CS, Michel S, Itri J, Rodriguez W, Tam J, Lelievre V, Hu Z, Liu X, Waschek JA. Disrupted circadian rhythms in VIP- and PHI-deficient mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 285: R939-49. PMID 12855416 DOI: 10.1152/ajpregu.00200.2003  0.76
2002 Nicot A, Lelièvre V, Tam J, Waschek JA, DiCicco-Bloom E. Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 9244-54. PMID 12417650  0.76
2002 Hu Z, Lelievre V, Rodriguez WI, Cheng JW, Waschek JA. Comparative distributions of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor mRNA in the frog (Xenopus laevis) brain. Regulatory Peptides. 109: 15-26. PMID 12409210 DOI: 10.1016/S0167-0115(02)00166-0  0.76
2002 Degerman A, Chun D, Nguyen TB, Bravo DT, Alanis J, Rökaeus A, Waschek JA. Local action of estrogen and thyroid hormone on vasoactive intestinal peptide (VIP) and galanin gene expression in the rat anterior pituitary. Neuropeptides. 36: 50-7. PMID 12147214 DOI: 10.1054/npep.2002.0886  0.76
2002 Waschek JA. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Developmental Neuroscience. 24: 14-23. PMID 12145407 DOI: 10.1159/000064942  0.76
2002 Lelievre V, Hu Z, Byun JY, Ioffe Y, Waschek JA. Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition. Journal of Neuroscience Research. 67: 566-73. PMID 11891769 DOI: 10.1002/jnr.10153  0.76
2001 Hu Z, Lelievre V, Rodriguez WI, Tam J, Cheng JW, Cohen-Cory S, Waschek JA. Embryonic expression of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor gene in the frog Xenopus laevis neural tube. The Journal of Comparative Neurology. 441: 266-75. PMID 11745649 DOI: 10.1002/cne.1411  0.76
2001 Lelièvre V, Pineau N, Hu Z, Ioffe Y, Byun JY, Muller JM, Waschek JA. Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways. The Journal of Biological Chemistry. 276: 43668-76. PMID 11553633 DOI: 10.1074/jbc.M107341200  0.76
2001 Tseng YT, Stabila JP, Nguyen TT, McGonnigal BG, Waschek JA, Padbury JF. A novel glucocorticoid regulatory unit mediates the hormone responsiveness of the beta1-adrenergic receptor gene. Molecular and Cellular Endocrinology. 181: 165-78. PMID 11476950 DOI: 10.1016/S0303-7207(01)00490-7  0.76
2001 Pineau N, Lelievre V, Goursaud S, Hilairet S, Waschek JA, Janet T, Muller JM. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes. Neuropeptides. 35: 117-26. PMID 11384207 DOI: 10.1054/npep.2001.0853  0.76
2001 Liu D, Krajniak K, Chun D, Sena M, Casillas R, Lelièvre V, Nguyen T, Bravo D, Colburn S, Waschek JA. VIP gene transcription is regulated by far upstream enhancer and repressor elements. Biochemical and Biophysical Research Communications. 284: 211-8. PMID 11374892 DOI: 10.1006/bbrc.2001.4948  0.76
2001 Lee M, Lelievre V, Zhao P, Torres M, Rodriguez W, Byun JY, Doshi S, Ioffe Y, Gupta G, de los Monteros AE, de Vellis J, Waschek J. Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3849-59. PMID 11356873  0.76
2000 Hu Z, Lelievre V, Tam J, Cheng JW, Fuenzalida G, Zhou X, Waschek JA. Molecular Cloning of Growth Hormone-Releasing Hormone/Pituitary Adenylyl Cyclase-Activating Polypeptide in the Frog Xenopus laevis: Brain Distribution and Regulation after Castration1†. Endocrinology. 141: 3366-3376. PMID 28201253 DOI: 10.1210/endo.141.9.7663  0.6
2000 Hu Z, Lelievre V, Chao A, Zhou X, Waschek JA. Characterization and Messenger Ribonucleic Acid Distribution of a Cloned Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor in the Frog Xenopus laevis Brain1. Endocrinology. 141: 657-665. PMID 28200957 DOI: 10.1210/endo.141.2.7316  0.6
2000 Waschek JA, Dicicco-Bloom EM, Lelievre V, Zhou X, Hu Z. PACAP action in nervous system development, regeneration, and neuroblastoma cell proliferation. Annals of the New York Academy of Sciences. 921: 129-36. PMID 11193816  0.76
2000 Koh SW, Waschek JA. Corneal endothelial cell survival in organ cultures under acute oxidative stress: effect of VIP. Investigative Ophthalmology & Visual Science. 41: 4085-92. PMID 11095600  0.76
2000 Hu Z, Lelievre V, Tam J, Cheng JW, Fuenzalida G, Zhou X, Waschek JA. Molecular cloning of growth hormone-releasing hormone/pituitary adenylyl cyclase-activating polypeptide in the frog Xenopus laevis: brain distribution and regulation after castration. Endocrinology. 141: 3366-76. PMID 10965909 DOI: 10.1210/endo.141.9.7663  0.76
2000 Hu Z, Lelievre V, Chao A, Zhou X, Waschek JA. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain. Endocrinology. 141: 657-65. PMID 10650947 DOI: 10.1210/endo.141.2.7316  0.76
1999 Waschek JA, Bravo DT, Sena M, Casillas R, Rodriguez W, Nguyen T, Colburn S. Targeting of embryonic and postnatal autonomic and enteric neurons with a vasoactive intestinal peptide transgene. Journal of Neurochemistry. 73: 1739-48. PMID 10501223 DOI: 10.1046/j.1471-4159.1999.731739.x  0.76
1999 Zhou X, Rodriguez WI, Casillas RA, Ma V, Tam J, Hu Z, Lelievre V, Chao A, Waschek JA. Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus. Journal of Neuroscience Research. 57: 953-61. PMID 10467267 DOI: 10.1002/(SICI)1097-4547(19990915)57:6<953::AID-JNR21>3.0.CO;2-R  0.76
1998 Rökaeus A, Jiang K, Spyrou G, Waschek JA. Transcriptional control of the galanin gene. Tissue-specific expression and induction by NGF, protein kinase C, and estrogen. Annals of the New York Academy of Sciences. 863: 1-13. PMID 9928155 DOI: 10.1111/j.1749-6632.1998.tb10679.x  0.76
1998 Rökaeus A, Waschek JA. Tissue-specific enhancement and restriction of galanin gene expression in transgenic mice by 5' flanking sequences. Brain Research. Molecular Brain Research. 60: 150-9. PMID 9757022 DOI: 10.1016/S0169-328X(98)00162-4  0.76
1998 Waschek JA, Casillas RA, Nguyen TB, DiCicco-Bloom EM, Carpenter EM, Rodriguez WI. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proceedings of the National Academy of Sciences of the United States of America. 95: 9602-7. PMID 9689127 DOI: 10.1073/pnas.95.16.9602  0.44
1998 Lelièvre V, Pineau N, Du J, Wen CH, Nguyen T, Janet T, Muller JM, Waschek JA. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase. The Journal of Biological Chemistry. 273: 19685-90. PMID 9677397 DOI: 10.1074/jbc.273.31.19685  0.76
1998 Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacological Reviews. 50: 265-70. PMID 9647867  0.76
1997 Waschek JA, Lelievre V, Bravo DT, Nguyen T, Muller JM. Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines. Peptides. 18: 835-41. PMID 9285932 DOI: 10.1016/S0196-9781(97)00015-6  0.76
1996 Waschek JA. VIP and PACAP receptor-mediated actions on cell proliferation and survival. Annals of the New York Academy of Sciences. 805: 290-300; discussion . PMID 8993411  0.76
1996 Fujieda S, Waschek JA, Zhang K, Saxon A. Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells. The Journal of Clinical Investigation. 98: 1527-32. PMID 8833899 DOI: 10.1172/JCI118944  0.76
1996 Waschek JA, Ellison J, Bravo DT, Handley V. Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. Journal of Neurochemistry. 66: 1762-5. PMID 8627335  0.76
1996 Tseng YT, McGonniyal B, Waschek JA, Padburv JF. Promoter functional analysis of the ovine β1-adrenergic receptor (01ar) gene Faseb Journal. 10: A417.  0.76
1995 Waschek JA, Bravo DT, Richards ML. High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells. Regulatory Peptides. 60: 149-57. PMID 8746541 DOI: 10.1016/0167-0115(95)00124-7  0.76
1995 Padbury JF, Tseng YT, Waschek JA. A cloning strategy for G-protein-coupled hormone receptors: the ovine beta 1-adrenergic receptor. Reproduction, Fertility, and Development. 7: 521-5. PMID 8606964  0.76
1995 Padbury JF, Tseng YT, Waschek JA. Transcription initiation is localized to a TATAless region in the ovine beta 1 adrenergic receptor gene. Biochemical and Biophysical Research Communications. 211: 254-61. PMID 7779093 DOI: 10.1006/bbrc.1995.1804  0.76
1995 Tseng YT, Tucker MA, Kashiwai KT, Waschek JA, Padbury JF. Regulation of beta 1-adrenoceptors by glucocorticoids and thyroid hormones in fetal sheep. European Journal of Pharmacology. 289: 353-9. PMID 7621909 DOI: 10.1016/0922-4106(95)90113-2  0.76
1995 Waschek JA. Vasoactive intestinal peptide: an important trophic factor and developmental regulator? Developmental Neuroscience. 17: 1-7. PMID 7621745  0.76
1995 Waschek JA, Richards ML, Bravo DT. Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines. Cancer Letters. 92: 143-9. PMID 7600524 DOI: 10.1016/0304-3835(95)03768-R  0.76
1995 Waschek JA. Transgenic targeting of neuroendocrine peptide genes in the hypothalamic-pituitary axis. Molecular Neurobiology. 10: 205-17. PMID 7576308 DOI: 10.1007/BF02740676  0.76
1995 Tseng YT, Waschek JA, Padbury JF. Functional analysis of the 5' flanking sequence in the ovine beta 1-adrenergic receptor gene. Biochemical and Biophysical Research Communications. 215: 606-12. PMID 7487998 DOI: 10.1006/bbrc.1995.2507  0.76
1995 Waschek JA, Agoston Dv. Introduction Molecular Neurobiology. 10: ix-x. DOI: 10.1007/BF02740667  0.76
1994 Sena M, Bravo DT, Von Agoston D, Waschek JA. High conservation of upstream regulatory sequences on the human and mouse vasoactive intestinal peptide (VIP) genes. Dna Sequence : the Journal of Dna Sequencing and Mapping. 5: 25-9. PMID 7894056 DOI: 10.3109/10425179409039701  0.76
1994 Rökaeus A, Waschek JA. Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells. Dna and Cell Biology. 13: 845-55. PMID 7520703  0.76
1992 Agoston DV, Colburn S, Krajniak KG, Waschek JA. Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells. Neuroscience Letters. 139: 213-6. PMID 1319016 DOI: 10.1016/0304-3940(92)90555-L  0.76
1990 Agoston DV, Bravo DT, Waschek JA. Expression of a chimeric VIP gene is targeted to the intestine in transgenic mice. Journal of Neuroscience Research. 27: 479-86. PMID 2079711 DOI: 10.1002/jnr.490270407  0.76
1989 Waschek JA, Muller JM, Duan DS, Sadée W. Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y. Febs Letters. 250: 611-4. PMID 2546814 DOI: 10.1016/0014-5793(89)80806-3  0.76
1989 Muller JM, Lolait SJ, Yu VC, Sadée W, Waschek JA. Functional vasoactive intestinal polypeptide (VIP) receptors in human neuroblastoma subclones that contain VIP precursor mRNA and release VIP-like substances. The Journal of Biological Chemistry. 264: 3647-50. PMID 2537287  0.76
1988 Waschek JA, Fielding RM, Tozer TN, Effeney DJ, Pond SM. Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs. Journal of Pharmacokinetics and Biopharmaceutics. 16: 151-9. PMID 3418492 DOI: 10.1007/BF01062257  0.76
1988 Waschek JA, Eiden LE. Calcium requirements for barium stimulation of enkephalin and vasoactive intestinal peptide biosynthesis in adrenomedullary chromaffin cells. Neuropeptides. 11: 39-45. PMID 3368036 DOI: 10.1016/0143-4179(88)90026-1  0.76
1988 Pond SM, Waschek JA, Mahacha V, Fielding RM, Effeney DJ, Tozer TN. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition. The Journal of Pharmacology and Experimental Therapeutics. 245: 291-3. PMID 3361447  0.76
1988 Waschek JA, Hsu CM, Eiden LE. Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5'-flanking sequence. Proceedings of the National Academy of Sciences of the United States of America. 85: 9547-51. PMID 3200839  0.76
1987 Dave JR, Eiden LE, Lozovsky D, Waschek JA, Eskay RL. Calcium-independent and calcium-dependent mechanisms regulate corticotropin-releasing factor-stimulated proopiomelanocortin peptide secretion and messenger ribonucleic acid production. Endocrinology. 120: 305-10. PMID 3490963 DOI: 10.1210/endo-120-1-305  0.76
1987 Rubin GM, Waschek JA, Pond SM, Effeney DJ, Tozer TN. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism. Journal of Pharmacokinetics and Biopharmaceutics. 15: 615-31. PMID 3450845 DOI: 10.1007/BF01068416  0.76
1987 Waschek JA, Pruss RM, Siegel RE, Eiden LE, Bader MF, Aunis D. Regulation of enkephalin, VIP, and chromogranin biosynthesis in actively secreting chromaffin cells. Multiple strategies for multiple peptides. Annals of the New York Academy of Sciences. 493: 308-23. PMID 3035984  0.76
1987 Waschek JA, Dave JR, Eskay RL, Eiden LE. Barium distinguishes separate calcium targets for synthesis and secretion of peptides in neuroendocrine cells. Biochemical and Biophysical Research Communications. 146: 495-501. PMID 2956945 DOI: 10.1016/0006-291X(87)90556-0  0.76
1986 Waschek JA, Fielding RM, Tozer TN, Effeney DJ, Pond SM. Availability of plasma sulfate for conjugation of salicylamide in dogs. Biochemical Pharmacology. 35: 544-6. PMID 3947388 DOI: 10.1016/0006-2952(86)90235-2  0.76
1986 Fielding RM, Waschek JA, Effeney DJ, Pogany AC, Pond SM, Tozer TN. Extrahepatic extraction of salicylamide in dogs. The Journal of Pharmacology and Experimental Therapeutics. 236: 97-102. PMID 3941404  0.76
1985 Waschek JA, Fielding RM, Pond SM, Rubin GM, Effeney DJ, Tozer TN. Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration. The Journal of Pharmacology and Experimental Therapeutics. 234: 431-4. PMID 4020679  0.76
1984 Waschek JA, Rubin GM, Tozer TN, Fielding RM, Couet WR, Effeney DJ, Pond SM. Dose-dependent bioavailability and metabolism of salicylamide in dogs. The Journal of Pharmacology and Experimental Therapeutics. 230: 89-93. PMID 6747835  0.76
1984 Fielding RM, Waschek JA, Rubin GM, Pond SM, Tozer TN. Analysis of Salicylamide and its Metabolites in Blood and Urine by Hplc Journal of Liquid Chromatography. 7: 1221-1234. DOI: 10.1080/01483918408074039  0.76
Show low-probability matches.